EUROFINS SCIENT Share Holder Equity 2018-2023 | ERFSF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EUROFINS SCIENT share holder equity from 2018 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EUROFINS SCIENT share holder equity from 2018 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$124.8B
Cencora (COR)	$44.6B
ICON (ICLR)	$24.8B
DiDi Global (DIDIY)	$19.2B
Avantor (AVTR)	$18.8B
Natera (NTRA)	$15.7B
Revvity (RVTY)	$15.6B
Viatris (VTRS)	$14.2B
CochLear (CHEOY)	$12.7B
Solventum (SOLV)	$12.5B
Medpace Holdings (MEDP)	$11.4B
Charles River Laboratories (CRL)	$10.8B
Sonic Healthcare (SKHHY)	$8.8B
Doximity (DOCS)	$7.5B
Bausch + Lomb (BLCO)	$7B
HealthEquity (HQY)	$6.9B
PACS (PACS)	$6.3B
Organon (OGN)	$5.2B
Life Times (LTH)	$5B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.2B
Concentras Parent (CON)	$2.9B
GoodRx Holdings (GDRX)	$2.7B
BrightSpring Health Services (BTSG)	$2.6B
Ardent Health Partners (ARDT)	$2.6B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$1.9B
AMN Healthcare Services Inc (AMN)	$1.7B
Agilon Health (AGL)	$1.6B